Neuland Laboratories Statistics

Total Valuation

Neuland Laboratories has a market cap or net worth of INR 199.47 billion. The enterprise value is 198.66 billion.

Market Cap	199.47B
Enterprise Value	198.66B

Important Dates

The last earnings date was Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	Jul 12, 2024

Share Statistics

Neuland Laboratories has 12.83 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	12.83M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	37.50%
Owned by Institutions (%)	19.87%
Float	7.14M

Valuation Ratios

The trailing PE ratio is 71.33 and the forward PE ratio is 59.61.

PE Ratio	71.33
Forward PE	59.61
PS Ratio	13.05
PB Ratio	14.30
P/TBV Ratio	n/a
P/FCF Ratio	482.47
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 48.08, with an EV/FCF ratio of 480.52.

EV / Earnings	71.04
EV / Sales	13.00
EV / EBITDA	48.08
EV / EBIT	56.72
EV / FCF	480.52

Financial Position

The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.08.

Current Ratio	2.34
Quick Ratio	1.20
Debt / Equity	0.08
Debt / EBITDA	0.27
Debt / FCF	2.65
Interest Coverage	42.92

Financial Efficiency

Return on equity (ROE) is 22.13% and return on invested capital (ROIC) is 15.99%.

Return on Equity (ROE)	22.13%
Return on Assets (ROA)	12.13%
Return on Capital (ROIC)	15.99%
Revenue Per Employee	9.30M
Profits Per Employee	1.70M
Employee Count	1,643
Asset Turnover	0.85
Inventory Turnover	2.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +198.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+198.15%
50-Day Moving Average	13,448.45
200-Day Moving Average	9,115.16
Relative Strength Index (RSI)	59.82
Average Volume (20 Days)	2,940

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neuland Laboratories had revenue of INR 15.28 billion and earned 2.80 billion in profits. Earnings per share was 217.98.

Revenue	15.28B
Gross Profit	7.97B
Operating Income	3.50B
Pretax Income	3.76B
Net Income	2.80B
EBITDA	4.10B
EBIT	3.50B
Earnings Per Share (EPS)	217.98

Full Income Statement

Balance Sheet

The company has 1.90 billion in cash and 1.09 billion in debt, giving a net cash position of 808.72 million or 63.03 per share.

Cash & Cash Equivalents	1.90B
Total Debt	1.09B
Net Cash	808.72M
Net Cash Per Share	63.03
Equity (Book Value)	13.95B
Book Value Per Share	1,087.53
Working Capital	5.53B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.46 billion and capital expenditures -2.04 billion, giving a free cash flow of 413.44 million.

Operating Cash Flow	2.46B
Capital Expenditures	-2.04B
Free Cash Flow	413.44M
FCF Per Share	32.22

Full Cash Flow Statement

Margins

Gross margin is 52.14%, with operating and profit margins of 22.92% and 18.30%.

Gross Margin	52.14%
Operating Margin	22.92%
Pretax Margin	24.60%
Profit Margin	18.30%
EBITDA Margin	26.82%
EBIT Margin	22.92%
FCF Margin	2.71%

Dividends & Yields

This stock pays an annual dividend of 14.00, which amounts to a dividend yield of 0.09%.

Dividend Per Share	14.00
Dividend Yield	0.09%
Dividend Growth (YoY)	40.00%
Years of Dividend Growth	2
Payout Ratio	6.42%
Buyback Yield	-0.01%
Shareholder Yield	0.08%
Earnings Yield	1.40%
FCF Yield	0.21%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a